| |
Our portfolio
Our
portfolio | Investment Guidelines |
Valuation Guidelines
|
Performance of ProgressNow!
|
as
per 30.04.2012
|
| Share price (SWX Swiss
Exchange) |
CHF 5.40 |
| Performance since 1.1.2012 |
-10.0% |
| Net Asset Value (preliminary unaudited
figure) |
CHF 11.85 |
|
Portfolio
|
as per 30.04.2012 |
| Company |
Amount |
Historical
price |
Current
valuation
per share |
+ / - |
Fair value
(in CHF) |
% of
portfolio |
| Enablearning, Inc | 1'452'905 | USD 0.87 | USD 0.00 | -100.0% | 0.00 | 0.0% | | Hansen Medical, Inc | 63'011 | USD 5.60 | USD 3.16 | -43.6% | 180'716.56 | 2.6% | | Oceanlinx Ltd | 348'179 | AUD 2.00 | AUD 0.35 | -82.5% | 115'135.83 | 1.6% | | Velico Medical, Inc | 9'906'585 | USD 0.92 | USD 0.75 | -18.4% | 6'743'412.41 | 95.8% |
|
Total (in CHF)
|
7'039'264.80 |
100.0% |
Exchange rate in CHF | | USD | 0.9076 | | AUD | 0.9448 | | GBP | 1.4739 |
|
|
